Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink
Today we are happy to announce the closing of a CHF 4.0M($4.3M) round of seed funding led by digital health investor, SeedLink, with additional funding from LabCorp, Athensmed, Swiss based Privilege Ventures and other European and US investors. Biospectal will leverage the new funds to scale its OptiBP™ smartphone blood pressure monitoring application and data
Biospectal Announces Two Independent Global Health Research and Validation Studies
We’re proud to announce two independent global research and validation studies which integrate the Biospectal OptiBP™ blood pressure measurement app. Currently underway in four low-resource countries, the studies center on the routine measurement and monitoring of blood pressure, assessment of hypertension during pregnancy, and enable global field testing and validation of Biospectal’s OptiBP smartphone app
Biospectal Wins a Coveted Spot on the Swiss National Mobile Startup Team at MWC Barcelona 2021
We’re excited to announce Biospectal has been chosen as one of 10 companies selected to represent Switzerland on the global stage at MWC Barcelona (June 28–July 1, 2021). We look forward to attending and meeting with top-notch investors and industry leaders at several of MWC’s key events, such as the 4YFN startup conference. Selected from
5 Blood Pressure Facts on World Hypertension Day 2021
This year on World Hypertension Day, the theme is “Measure Your Blood Pressure Accurately, Control It, Live Longer.” More than one billion people around the world live with hypertension (high blood pressure), putting them at risk of avoidable medical complications and death. We believe the answer is more frequent and meaningful monitoring. The United Nations
Biospectal’s OptiBP Smartphone Software Achieves Blood Pressure Cuff Accuracy in Breakthrough Study Published in Scientific Reports in Nature
Scientific Reports in Nature has published the breakthrough results of our in depth research conducted at the University of Lausanne, Switzerland’s CHUV hospital by Professor Patrick Schoettker. Focusing on optical blood pressure sensing using only the fingertip on a smartphone camera, the study demonstrated that our OptiBP™ software has achieved equivalency with the traditional blood
Biospectal Recognized as Top Remote Patient Monitoring Startup by High Tech Connect at International E-Healthcare Applications Summit
Our Biospectal team had a great day today being selected as runner up out of 160 contestants as a top startup innovator in remote patient monitoring at High Tech Connect’s International E-Healthcare Applications Summit in Winterthur, Switzerland! With the event’s theme of discovering “world-leading digital health technologies and hospital use cases,” we clearly showed that